Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia De Rossi

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Blood|April 28, 2016
Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cellsDawn T Smallwood, Benedetta Apollonio, Shaun Willimott, et al.
Investigative Ophthalmology & Visual Science|July 11, 2022
Functional Changes Within the Rod Inner Segment Ellipsoid in Wildtype Mice: An Optical Coherence Tomography and Electron Microscopy StudyBruce A Berkowitz, Robert H Podolsky, Karen Lins Childers, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signallingLars Godmann, Miriam Bollmann, Adelheid Korb-Pap, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2021
Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin InternalizationGiulia De Rossi, Maria Vähätupa, Enrico Cristante, et al.
Cells|April 25, 2025
LRG1 Alters Pericyte Phenotype and Compromises Vascular MaturationAlexandra E Hoeh, Jui-Hsien Chang, Ronja S Mueller, et al.
Blood|October 12, 2023
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trialDespoina Papazoglou, Xin Victoria Wang, Tait D Shanafelt, et al.
British Journal of Pharmacology|October 21, 2024
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degenerationSamantha Arokiasamy, Michaela J M Balderstone, Faheem Shaik, et al.
Science Translational Medicine|October 22, 2025
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in miceGiulia De Rossi, Ao-Wang Qiu, Maxime Berg, et al.
Development (Cambridge, England)|April 5, 2018
Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent mannerEnrico Cristante, Sidath E Liyanage, Robert D Sampson, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2021
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary FibrosisKonstantin Tsoyi, Xiaoliang Liang, Giulia De Rossi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Blood|April 28, 2016
Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cellsDawn T Smallwood, Benedetta Apollonio, Shaun Willimott, et al.
Investigative Ophthalmology & Visual Science|July 11, 2022
Functional Changes Within the Rod Inner Segment Ellipsoid in Wildtype Mice: An Optical Coherence Tomography and Electron Microscopy StudyBruce A Berkowitz, Robert H Podolsky, Karen Lins Childers, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signallingLars Godmann, Miriam Bollmann, Adelheid Korb-Pap, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2021
Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin InternalizationGiulia De Rossi, Maria Vähätupa, Enrico Cristante, et al.
Cells|April 25, 2025
LRG1 Alters Pericyte Phenotype and Compromises Vascular MaturationAlexandra E Hoeh, Jui-Hsien Chang, Ronja S Mueller, et al.
Blood|October 12, 2023
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trialDespoina Papazoglou, Xin Victoria Wang, Tait D Shanafelt, et al.
British Journal of Pharmacology|October 21, 2024
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degenerationSamantha Arokiasamy, Michaela J M Balderstone, Faheem Shaik, et al.
Science Translational Medicine|October 22, 2025
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in miceGiulia De Rossi, Ao-Wang Qiu, Maxime Berg, et al.
Development (Cambridge, England)|April 5, 2018
Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent mannerEnrico Cristante, Sidath E Liyanage, Robert D Sampson, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2021
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary FibrosisKonstantin Tsoyi, Xiaoliang Liang, Giulia De Rossi, et al.
Pageof 3